These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 18360697

  • 1. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Enjoji M, Takayanagi R, Nakamuta M.
    Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
    [Abstract] [Full Text] [Related]

  • 2. Regulation of synthesis and oxidation of fatty acids by adiponectin receptors (AdipoR1/R2) and insulin receptor substrate isoforms (IRS-1/-2) of the liver in a nonalcoholic steatohepatitis animal model.
    Matsunami T, Sato Y, Ariga S, Sato T, Shimomura T, Kashimura H, Hasegawa Y, Yukawa M.
    Metabolism; 2011 Jun; 60(6):805-14. PubMed ID: 20846698
    [Abstract] [Full Text] [Related]

  • 3. TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).
    Endo M, Masaki T, Seike M, Yoshimatsu H.
    Exp Biol Med (Maywood); 2007 May; 232(5):614-21. PubMed ID: 17463157
    [Abstract] [Full Text] [Related]

  • 4. [Expression and action of hepatic sterol regulatory element-binding protein-1c in patients with nonalcoholic fatty liver disease].
    Yang ZX, Sun H, Shen W.
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):823-6. PubMed ID: 19032865
    [Abstract] [Full Text] [Related]

  • 5. Effect of exercise and insulin on SREBP-1c expression in human skeletal muscle: potential roles for the ERK1/2 and Akt signalling pathways.
    Boonsong T, Norton L, Chokkalingam K, Jewell K, Macdonald I, Bennett A, Tsintzas K.
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1310-1. PubMed ID: 17956338
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M, Kohjima M, Morizono S, Kotoh K, Yoshimoto T, Miyagi I, Enjoji M.
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [Abstract] [Full Text] [Related]

  • 7. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Kohjima M, Enjoji M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T, Yada M, Yada R, Harada N, Takayanagi R, Nakamuta M.
    Int J Mol Med; 2007 Sep; 20(3):351-8. PubMed ID: 17671740
    [Abstract] [Full Text] [Related]

  • 8. Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways.
    Park KG, Min AK, Koh EH, Kim HS, Kim MO, Park HS, Kim YD, Yoon TS, Jang BK, Hwang JS, Kim JB, Choi HS, Park JY, Lee IK, Lee KU.
    Hepatology; 2008 Nov; 48(5):1477-86. PubMed ID: 18972440
    [Abstract] [Full Text] [Related]

  • 9. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
    Nakamuta M, Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Yada M, Yada R, Takemoto R, Fukuizumi K, Harada N, Taketomi A, Maehara Y, Nakashima M, Enjoji M.
    Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
    [Abstract] [Full Text] [Related]

  • 10. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
    McPherson S, Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE.
    J Hepatol; 2008 Dec; 49(6):1046-54. PubMed ID: 18752865
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver.
    Xing LJ, Zhang L, Liu T, Hua YQ, Zheng PY, Ji G.
    Eur J Pharmacol; 2011 Oct 15; 668(3):467-71. PubMed ID: 21839075
    [Abstract] [Full Text] [Related]

  • 13. Insulin immuno-neutralization in chicken: effects on insulin signaling and gene expression in liver and muscle.
    Dupont J, Tesseraud S, Derouet M, Collin A, Rideau N, Crochet S, Godet E, Cailleau-Audouin E, Métayer-Coustard S, Duclos MJ, Gespach C, Porter TE, Cogburn LA, Simon J.
    J Endocrinol; 2008 Jun 15; 197(3):531-42. PubMed ID: 18492818
    [Abstract] [Full Text] [Related]

  • 14. Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs.
    Dif N, Euthine V, Gonnet E, Laville M, Vidal H, Lefai E.
    Biochem J; 2006 Nov 15; 400(1):179-88. PubMed ID: 16831124
    [Abstract] [Full Text] [Related]

  • 15. Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice.
    Yang J, Maika S, Craddock L, King JA, Liu ZM.
    Biochem Biophys Res Commun; 2008 May 30; 370(2):248-53. PubMed ID: 18381066
    [Abstract] [Full Text] [Related]

  • 16. [Role of JNK signal transduction pathway in nonalcoholic fatty liver disease].
    Tan Y, Zhang JN, Chen JH, Wang LJ, Liu HX.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 30; 17(11):821-5. PubMed ID: 19958640
    [Abstract] [Full Text] [Related]

  • 17. Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.
    Lemoine M, Barbu V, Girard PM, Kim M, Bastard JP, Wendum D, Paye F, Housset C, Capeau J, Serfaty L.
    AIDS; 2006 Feb 14; 20(3):387-95. PubMed ID: 16439872
    [Abstract] [Full Text] [Related]

  • 18. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
    Deng X, Dong Q, Bridges D, Raghow R, Park EA, Elam MB.
    Biochim Biophys Acta; 2015 Dec 14; 1851(12):1521-9. PubMed ID: 26327595
    [Abstract] [Full Text] [Related]

  • 19. Insulin regulation of glucokinase gene expression: evidence against a role for sterol regulatory element binding protein 1 in primary hepatocytes.
    Gregori C, Guillet-Deniau I, Girard J, Decaux JF, Pichard AL.
    FEBS Lett; 2006 Jan 23; 580(2):410-4. PubMed ID: 16380121
    [Abstract] [Full Text] [Related]

  • 20. Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress.
    Liu JF, Ma Y, Wang Y, Du ZY, Shen JK, Peng HL.
    Phytother Res; 2011 Apr 23; 25(4):588-96. PubMed ID: 20925133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.